• English
• サイトマップ
• 求人情報
• アクセス
• お問い合わせ

更新日：2019年9月7日

1. 論文
   1. 委員会承認の治療研究

      JCOG0403

      Y Nagata, M Hiraoka, T Shibata, et al.: Prospective trial of stereotactic body radiation therapy for both operable and inoperable T1N0M0 non-small-cell lung cancer: Japan clinical oncology group study JCOG0403. Int J Radiat Oncol Biol Phys. 93(5): 989-996, 2015.

      JCOG0701

      K Nakamura, T Kodaira, N Shikama, et al.: Accelerated Fractionation versus Conventional Fractionation Radiation Therapy for Glottic Cancer of T1-2N0M0 Phase III Study: Japan Clinical Oncology Group Study (JCOG 0701). Jpn J Clin Oncol. 38: 387-389, 2008.

      T Kodaira, Y Kagami, T Shibata, et al.: Results of a multi-institutional, randomized, non-inferiority, phase 3 trial of accelerated fractionation versus standard fractionation in radiation therapy for T1-2N0M0 glottic cancer: Japan Clinical Oncology Group study (JCOG0701). Annals of Oncology. 29(4), 992-997, 2018.

      JCOG0702

      R Onimaru, H Shirato, T Shibata, et al.: Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer with PTV<100cc using a continual reassessment method (JCOG0702). Radiother Oncol. 116(2): 276-280, 2015.

      R Onimaru, H Onishi, T Shibata, et al.: Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702): Results for the group with PTV100cc. Radiother Oncol. 122(2): 281-285, 2017.

      R Onimaru, H Onishi, G Ogawa, et al.: Final Report of Survival and Late Toxicities in the Phase I Study of Stereotactic Body Radiation Therapy for Peripheral T2N0M0 Non-Small Cell Lung Cancer (JCOG0702). Jpn J Clin Oncol. 48(12): 1076-1082, 2018.

      JCOG0906

      M Nozaki, K Kagami, T Shibata, et al.: A primary analysis of a multicenter, prospective, single-arm, confirmatory trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906. Jpn J Clin Oncol 49(1): 57-62, 2019.

      JCOG1315C

      T Nishio, H Tachibana, Y Kase Y, et al.: Liver phantom design and dosimetric verification in participating institutions for a proton beam therapy in patients with resectable hepatocellular carcinoma: Japan Clinical Oncology Group trial (JCOG1315C). Radiother Oncol. 140: 98-104, 2019.

      JCOG1402

      H Okamoto, N Murakami, F Isohashi, et al.: Dummy-run for standardizing plan quality of intensity-modulated radiotherapy for postoperative uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402). Radiat Oncol. 140(1): 133, 2019.

      N Murakami, F Isohashi, Y Hasumi, et al.: Single-arm confirmatory trial of postoperative concurrent chemoradiotherapy using intensity modulated radiation therapy for patients with high-risk uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402). Jpn J Clin Oncol (in press).

      JCOG1408

      D Kawahara, S Ozawa, T Kimura, et al.: Marginal prescription equivalent to the isocenter prescription in lung stereotactic body radiotherapy: preliminary study for Japan Clinical Oncology Group trial (JCOG1408). J Radiat Res. 58(1): 149-154, 2017.

      T Kimura, Y Nagata, J Eba, et al.: A randomized phase III trial of comparing two dose-fractionations stereotactic body radiotherapy (SBRT) for medically inoperable stage IA non-small cell lung cancer or small lung lesions clinically diagnosed as primary lung cancer: Japan Clinical Oncology Group Study JCOG1408 (J-SBRT trial). Jpn J Clin Oncol. 47: 277-281, 2017.

   2. グループ代表者管理の治療研究

      Y Nagata, K Takayama, Y Matsuo, et al.: Clinical outcomes of a Phase I/II study of 48Gy of stereotactic body radiation therapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 63: 1427-1431, 2005.

   3. 附随研究等

      関 智史、MD Hossain、国枝 悦夫、他: 異なる施設間での肺小腫瘤GTVの解析. 日放腫会誌. 17: 25-30, 2005.

      T Nishio, E Kunieda, H Shirato, et al.: Dosimetric verification in participating institutions in a stereotactic body radiotherapy trial for stage I non-small cell lung cancer: Japan Clinical Oncology Group trial (JCOG0403). Phys Med Biol. 51: 5409-5417, 2006.

      Y Matsuo, K Takayama, Y Nagata, et al.: Interinstitutional Variations in Planning for Stereotactic Body Radiation Therapy for Lung Cancer. Int J Radiat Oncol Biol Phys. 68: 416-425, 2007.

      T Toita, M Oguchi, T Kodaira, et al.: Quality assurance in the prospective multi-institutional trial on definitive radiotherapy using high-dose-rate intracavitary brachytherapy for uterine cervical cancer. The individual case review. Jpn J Clin Oncol. 39: 813-819, 2009.

      M Yamaguchi, M Oguchi, S Ishikura, et al.: Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211. J Clin Oncol. 27: 5594-5600, 2009.

      N Sanuki-Fujimoto, S Ishikura, K Hayakawa, et al.: Radiotherapy quality assurance review in a multi-center randomized trial of limited-disease small cell lung cancer: the Japan Clinical Oncology Group (JCOG) trial 0202. Radiation Oncology. 4: 16, 2009.

      T Toita, T Ohno, Y Kaneyasu, et al.: A consensus-based guideline defining the clinical target volume for pelvic lymph nodes in external beam radiotherapy for uterine cervical cancer. Jpn J Clin Oncol. 40: 456-463, 2010.

      T Toita, T Ohno, Y Kaneyasu, et al.: A consensus-based guideline defining clinical target volume (CTV) for primary disease in external beam radiotherapy for intact uterine cervical cancer. Jpn J Clin Oncol. 41: 1119-1126, 2011.

      N Sanuki, S Ishikura, M Shinoda, et al.: Radiotherapy quality assurance review for a multi-center randomized trial of locally advanced esophageal cancer: the Japan Clinical Oncology Group (JCOG) trial 0303. Int J Clin Oncol. 17: 105-111, 2012.

      M Nozaki, Y Kagami, M Mitsumori, et al.: A multiple investigation of Late adverse events in Japanese women treated with breast-conserving surgery plus conventional fractionated whole-breast radiation therapy. Jpn J Clin Oncol. 42: 522-527, 2012.

      G Kasuya, T Toita, K Furutani, et al.: Distribution patterns of metastatic pelvic lymph nodes assessed by CT/MRI in patients with uterine cervical cancer. Radiat Oncol. 8: 139, 2013.

      T Nishio, H Shirato, M Ishikawa, et al.: Design, development of water tank-type lung phantom and dosimetric verification in institutions participating in a phase I study of stereotactic body radiation therapy in patients with T2N0M0 non-small cell lung cancer: Japan Clinical Oncology Group trial (JCOG0702). J Radiat Res. 55: 600-607, 2014.

      C Melidis, WR Bosch, J Izewska, et al.: Global harmonization of quality assurance naming conventions in radiation therapy clinical trials. Int J Radiat Oncol Biol Phys. 90: 1242-1249, 2014.

      S Hatanaka, Y Miyabe, N Tohyama, et al.: Dose calculation accuracies in whole breast radiotherapy treatment planning: a multi-institutional study. Radiol Phys Technol. 8: 200-208, 2015.

      N Murakami, H Okamoto, F Isohashi, et al.: A surveillance study of intensity-modulated radiation therapy for postoperative cervical cancer in Japan. J Radiat Res. 56: 735-741, 2015.

      F Kunieda, T Kasamatsu, T Arimoto, et al.: Non-randomized confirmatory trial of modified radical hysterectomy for patients with tumor diameter 2 cm or less FIGO Stage IB1 uterine cervical cancer: Japan Clinical Oncology Group Study (JCOG1101). Jpn J Clin Oncol. 45: 123-126, 2015.

      M Tahara, N Fuse, J Mizusawa, et al.: Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604). Cancer Sci. 106: 1414-1420, 2015.

      J Eba, K Nakamura, J Mizusawa, et al. Stereotactic body radiotherapy versus lobectomy for operable clinical stage IA lung adenocarcinoma: comparison of survival outcomes in two clinical trials with propensity score analysis (JCOG1313-A). Jpn J Clin Oncol. 46:748-753, 2016.

      N Murakami, Y Norihisa, F Isohashi, et al.: Proposed definition of the vaginal cuff and paracolpium clinical target volume in postoperative uterine cervical cancer. Prct Radiat Oncol 6:5-11, 2016.

      M Nakamura, T Minemura, S Ishikura, et al.: An on-site audit system for dosimetry credentialing of intensity-modulated radiotherapy in Japanese Clinical Oncology Group (JCOG) clinical trials. Phys Med. 32: 987-991, 2016.

      M Hussein, E Clementel, D Eaton, et al.: A virtual dosimetry audit – Towards transferability of gamma index analysis between clinical trial QA groups. Radiother Oncol. 125: 398-404, 2017.

      D Kawai, R Takahashi, T Kamima, et al.: Variation of the prescription dose using the analytical anisotropic algorithm in lung stereotactic body radiation therapy. Phys Med. 38: 98-104, 2017.

      H Okamoto, N Murakami, C Carvajal, et al.: Positional uncertainty of vaginal cuff and feasibility of implementing portable bladder scanner in postoperative cervical cancer patients. Phys Med. 45: 1-5, 2018.

      H Okamoto, T Minemura, M Nakamura, et al.: Establishment of postal audit system in intensity-modulated radiotherapy by radiophotoluminescent glass dosimeters and a radiochromic film. Phys Med. 48: 119-126, 2018.

      Y Kumazaki, S Ozawa, M Nakamura, et al.: An end-to-end postal audit test to examine the coincidence between the imaging isocenter and treatment beam isocenter of the IGRT linac system for Japan Clinical Oncology Group (JCOG) clinical trials. Phys Med. 53: 145-152, 2018.

      T Inoue, N Katoh, Y Ito, et al.: Stereotactic body radiotherapy to treat small lung lesions clinically diagnosed as primary lung cancer by radiological examination: a prospective observational study. Lung Cancer. 122: 107-112, 2018.

      Y Matsuo : Sarcopenia is a potential factor for optimized treatment selection for elderly patients with early stage non-small cell lung cancer. J Thorac Dis. 11(Suppl 3): S443-S445, 2019.

      F Isohashi, T Takano, M Onuki, et al.: A multi-institutional observational study on the effects of three-dimensional radiotherapy and weekly 40-mg/m2 cisplatin on postoperative uterine cervical cancer patients with high-risk prognostic factors. Int J Clin Oncol. 24(5):575-582, 2019.

   4. 総説・解説

      佐野尚樹、佐々木潤一、西尾禎治、他: 体幹部定位放射線治療「ガイドラインの詳細とマニュアル」 大西 洋、平岡真寛 編著. 中外医学社. 2006.

      M Hiraoka, S Ishikura: A Japan Clinical Oncology Group Trial for Stereotactic Body Radiation Therapy of Non-Small Cell Lung Cancer. J Thorac Oncol. 2: S115-117, 2007.

      S Ishikura: Quality assurance of radiotherapy in cancer treatment: Toward improvement of patient safety and quality of care. Jpn J Clin Oncol. 38: 723-729, 2008.

      Y Nagata, J Wulf, I Lax, et al.: Stereotactic radiotherapy of primary lung cancer and other targets. Results of consultant meeting of the International Atomic Energy Agency (IAEA). Int J Radiat Oncol Biol Phys. 79: 660-669, 2010.

      S Ishikura, Y Ito, M Hiraoka: JCOG Radiation Therapy Study Group: History and achievements. Jpn J Clin Oncol. 41: 1241-1243, 2011.

      C Melidis, WR Bosch, J Izewska, et al.: Radiation therapy quality assurance in clinical trials--Global Harmonisation Group. Radiother Oncol. 111: 327-329, 2014.

      T Kodaira, Y Nishimura, Y Kagami, et al.: Definitive radiotherapy for head and neck squamous cell carcinoma: update and perspectives on the basis of EBM. Jpn J Clin Oncol. 45: 235-243, 2015.

      Y Nagata (editor): Stereotactic Body Radiation Therapy: Principles and Practices. Springer. 2015.

      Y Nishimura, R Komaki (editor): Intensity-Modulated Radiation Therapy: Clinical Evidence and Techniques. Springer. 2015.

2. 主な学会発表
   1. 委員会承認の治療研究

      Y Nagata, M Hiraoka, T Shibata, et al.: A phase II Trial of Stereotactic Body Radiation Therapy for Operable T1N0M0 Non-Small Cell Lung Cancer, Japan Clinical Oncology Group (JCOG0403). The 52nd ASTRO Annual Meeting. Oct 2010.

      T Kodaira, N Shikama, Y Kagami, et al.: Accelerated Fractionation versus Conventional Fractionation Radiation Therapy for Glottic Cancer of T1-2N0M0 Phase III Study: Japan Clinical Oncology Group Study (JCOG 0701). Th 27th Annual meeting of Korean Society for Therapeutic Radiology and Oncology. Oct 2010.

      M Hiraoka, Y Nagata, T Shibata, et al.: Results of a Phase II Study of Stereotactic Body Radiation Therapy for Operable T1N0M0 Non-Small Cell Lung Cancer by Japan Clinical Oncology Group (JCOG0403). 2010 Chicago Multidisciplinary Symposium in Thoracic Oncology. Dec 2010.

      Y Nagata, M Hiraoka, T Shibata, et al.: Stereotactic body radiation therapy for inoperable T1N0M0 non-small cell lung cancer: Analysis of the Japan Clinical Oncology Group study (JCOG0403). The 54th ASTRO Annual Meeting. Oct 2012.

      R Onimaru, H Shirato, T Shibata, et al.: A phase I study of stereotactic body radiotherapy (SBRT) for peripheral T2N0M0 non-small cell lung cancer (NSCLC): Japan Clinical Oncology Group Study (JCOG0702). The 55th ASTRO Annual Meeting. Sep 2013.

      T Kodaira, N Shikama, Y Kagami, et al.: Accelerated versus Conventional Fractionated Radiotherapy for Glottic Cancer of T1-2N0M0 (JCOG 0701): Comparison of acute toxicity of both group. 5th World Congress of IFHNOS and Annual Meeting of the AHNS. July 2014.

      齊籐吉弘、古平毅、鹿間直人、他: T1-2N0M0声門癌の加速照射と標準分割照射の第III相試験(JCOG0701): 早期安全性データ. 第52回癌治療学会. 2014年8月.

      M Nozaki, Y Kagami, M Hiraoka: Hypofractionated whole breast irradiation (HWBI): a review of some randomized trials and a multicenter prospective trial in Japan (JCOG0906). The 27th Annual Meeting of JASTRO, ESTRO/JASTRO Joint Symposium. Nov 2014.

      H Onishi, R Onimaru, H Shirato, et al.: Dose escalation study of stereotactic body radiotherapy (SBRT) for peripheral T2N0M0 non-small cell lung cancer (NSCLC) with PTV ≥ 100 cc: Japan Clinical Oncology Group Study (JCOG0702). The 57th ASTRO Annual Meeting. Oct 2015.

      Y Nishimura, T Kodaira, Y Ito, et al.: A Phase II Study of Intensity Modulated Radiation Therapy (IMRT) with Chemotherapy for Locoregionally Advanced Nasopharyngeal Cancer (NPC) (JCOG1015): Acute Toxicity and Treatment Compliance. The 58th ASTRO Annual Meeting, Boston. Sep 2016.

      T Kodaira, Y Kagami, T Shibata, et al.: Final analysis of a Randomized Phase III trial of Accelerated versus Conventional Fractionation Radiotherapy for Glottic Cancer of T1-2N0M0 (JCOG 0701). The 59™ ASTRO Annual Meeting. (Late Breaking Abstract) Sep 2016.

      M Nozaki, Y Kagami, M Hiraoka: Hypofractionated whole breast irradiation: consideration on a multicenter prospective trial in JCOG. The 29th JASTRO Annual Meeting. Nov 2016.

      K Konishi , T Kodaira, T Shibata: 早期声門癌に対する標準分割法と加速照射法の比較試験（JCOG0701） 最終報告 第29回日本放射線腫瘍学会学術大会. 2017年11月 Best papers session.

      M Nozaki, Y Kagami, T. Shibata, et al.: A clinical trial on hypofractionated whole-breast irradiation after breast-conserving surgery. The 36th ESTRO Annual Meeting. Wien. May 2017.

      H Onishi, Y Nagata, M Hiraoka, et al.: Radiation Pneumonitis and Change of Pulmonary Function after Stereotactic Body Radiotherapy for T1N0M0 Non-Small Cell Lung Cancer and Their Impact on Survival in a Supplementary Analysis of Japan Clinical Oncology Group (JCOG) Study JCOG0403. The 59th ASTRO Annual Meeting. Sep 2017.

      Y Nagata: Published clinical trials in Japan, JCOG0403: 2017 Trilateral Symposium. Dec 2017.

      Y Nagata: Ongoing clinical trials in Japan, JCOG1408: 2017 Trilateral Symposium. Dec 2017.

      Y Nagata, M Hiraoka, T Shibata, et al.: A phase II trial of stereotactic body radiation therapy for operable T1N0M0 non-small cell lung cancer: Japan Clinical Oncology Group (JCOG0403)—Long term follow-up results. The 54th ASCO Annual meeting. Jun 2018.

      Y Nagata, M Hiraoka, T Shibata, et al.: A Phase II Trial of Stereotactic Body Radiation Therapy for Operable T1N0M0 Non-Small Cell Lung Cancer. Japan Clinical Oncology Group (JCOG0403): Long Term Follow-up Results. The 60th ASTRO Annual Meeting. Oct 2018.

      Y Nishimura, T Kodaira, Y Ito, et al.: A Phase II Study of Two-step Intensity Modulated Radiation Therapy (IMRT) with Chemotherapy for Loco-regionally Advanced Nasopharyngeal Cancer (NPC) (JCOG1015). The 60th ASTRO Annual Meeting. Oct 2018.

      M Nozaki, Y Kagami, T. Shibata, et al.: A Multicenter Single-arm Confirmatory Trial on Hypofractionated Whole-breast Irradiation after Breast-conserving Surgery. The 60th ASTRO Annual Meeting. Oct 2018.

      M Nozaki, Y Kagami, M Takahashi, et al.: A comparison of breast cosmetic evaluation methods in hypofractionated whole breast irradiation. The 38th ESTRO Annual Meeting. May 2019.

      Y Nagata: A phase II Trial of Stereotactic Body Radiation Therapy for Operable T1N0M0 Non-Small Cell Lung Cancer. Japan Clinical Oncology Group (JCOG0403)： Long term follow-up results. The 7th Japan-Taiwan Radiation Oncology Symposium, May 2019.

   2. グループ代表者管理の治療研究

      なし

   3. 附随研究等

      T Nishio, M Shimbo, E Kunieda, et al.: Quality assurance of radiotherapy treatment planning system prior to stereotactic irradiation for lung tumor trial: Japan Clinical Oncology Group (JCOG) study. The 23th ESTRO Meeting. Oct 2004.

      Y Matsuo, K Takayama, Y Nagata, et al.: Results of Institutional Differences in Treatment Planning for a Multi-institutional Trial of Stereotactic Radiotherapy for T1N0M0 Lung Cancer (JCOG0403). The 47th ASTRO Annual Meeting. Oct 2005.

      M Oguchi, Y Kagami, S Ishikura, et al.: Upfront radiotherapy with concurrent chemotherapy for localized nasal NK/T-cell lymphoma: Radiotherapy quality assurance (QA) review in Japan Clinical Oncology Group (JCOG) trial 0211. The 50th ASTRO Annual Meeting. Sep 2008.

      S Ishikura, M Hiraoka, W Bosch, et al.: Radiotherapy quality assurance (QA) in a multi-center stereotactic body radiation therapy (SBRT) trial for stage IA non-small cell lung cancer: The Japan Clinical Oncology Group (JCOG) trial 0403. Fourth International Conference on Translational Research and Pre-Clinical Strategies in Radiation Oncology (ICTR). Mar 2009.

      西尾禎治、石川正純、小澤修一、他: 水タンク式肺ファントムを利用した治療計画装置の線量計算精度検証. 日本医学物理学会第99回学術大会. 2010年4月.

      野崎美和子、加賀美芳和、光森通英、他: 乳房温存療法の術後標準照射法における遅発性有害事象に関する多施設前向き調査．第23回日本放射線腫瘍学会. 2010年10月.

      畑中星吾、遠山尚紀、岡本裕之、他: 施設間における治療計画装置の線量計算精度の標準化に向けた基礎的検討-乳房接線照射-. 第23回日本放射線腫瘍学会. 2010年10月.

      T Toita, T Ohno, Y Kaneyasu, et al.: Clinical target volume (CTV) for primary disease in external beam radiotherapy for intact uterine cervical cancer. The 17th International Meeting of the European Society of Gynaecological Oncology. Sep 2011.

      Y Matsuo, S Ishikura, T Shibata, et al.: Dose-Volume Analysis in a Phase II Study of Stereotactic Body Radiation Therapy for cT1N0M0 Non-small Cell Lung Cancer (JCOG0403): Impact of Dose Calculation Algorithm with Heterogeneity Correction on Local Control in Operable Patients. The 53rd ASTRO Annual Meeting. Oct 2011.

      石川正純、Sutherland Kenneth、峯村俊行、他: 第三者評価におけるGradient法を用いたフィルム線量分布解析の合格基準に関する考察. 日本放射線腫瘍学会第25回学術大会. 2012年11月.

      C Melidis, WR Bosch, J Izewska, et al.: Harmonisation of quality assurance for clinical trials in radiotherapy. The 31st ESTRO Annual Meeting. May 2012.

      CW Hurkmans, M Ebert, Y Xiao, et al.: Harmonizing quality assurance procedures and corresponding naming conventions in clinical trials in radiotherapy. The 2nd ESTRO Forum. Apr 2013.

      T Kodaira: Japanese present status and future aspect of clinical practice for nasopharyngeal cancer. The 1st annual meeting Japan-Taiwan Conference on high precision radiation therapy. Aug 2013.

      野崎美和子、加賀美芳和、平岡眞寛: 寡分割全乳房照射. 第21回日本乳癌学会. 2013年6月.

      石川正純、小島秀樹、橘英伸、他: スキャナを用いたフィルム線量解析における実用的な誤差低減法. 日本医学物理学会第106回学術大会. 2013年9月.

      石川正純、峯村俊行、橘英伸、他: JCOG多施設共同研究におけるGradient法を用いたIMRT Credentialingの検討. 日本放射線腫瘍学会第26回学術大会. 2013年10月.

      T Nishio, H Shirato, M Ishikawa, et al.: Development of a water tank-type lung phantom for dose verification and credentialing of lung SBRT clinical trial. ESTRO 33. Apr 2014.

      H Okamoto, N Murakami, T Toita, et al.: Multi-institutional comparison of IMRT treatment planning for postoperative cervical cancer patients. The 73rd Annual Meeting of the Japan Radiological Society. Apr 2014.

      M Ishikawa, T Minemura, H Tachibana, et al.: Consideration of pass criteria for IMRT credentialing using the Gradient method in multi-institutional clinical trials. The 73rd Annual Meeting of the Japan Radiological Society. Apr 2014.

      J Eba, K Nakamura, J Mizusawa, et al.: Stereotactic body radiotherapy versus lobectomy for operable clinical stage IA pulmonary adenocarcinoma: Comparison of prospective clinical trials with propensity score analysis (JCOG1313-A). The 50th ASCO Annual Meeting. Jun 2014.

      M Ishikawa, T Minemura, H Tachibana, et al.: Consideration of pass criteria for IMRT credentialing using the Gradient method in multi-institutional clinical trials. The 7th JSMP-KSMP Joint Meeting on Medical Physics. Sep 2014.

      石川正純、峯村俊行、岡本裕之、他: 大型PTVに対するIMRT多施設共同研究における物理的Credentialingの検討. 日本放射線腫瘍学会第27回学術大会. 2014年12月.

      西尾禎治、岡本裕之、峯村俊行、他: 放射線治療多施設共同試験における包括的医学物理検証体制の構築. 日本医学物理学会第110回学術大会. 2015年9月.

      西尾禎治、河野良介、堀田健二、他: 肝臓陽子線治療の多施設臨床試験実施に向けた物理線量検証. 日本粒子線治療臨床研究会第12回学術大会. 2015年9月.

      C Clark, C Field, D Followill, et al.: Harmonising the clinical trials QA group reports on phantom measurements around the globe. The 35th ESTRO Annual Meeting. Apr 2016.

      K Nihei, K Minashi, M Muto, et al.: A phase II study of endoscopic resection and chemoradiotherapy for clinical stage I esophageal carcinoma (JCOG 0508): A report of radiation therapy quality assurance program. The 58th ASTRO Annual Meeting. Sep 2016.

      Y Matsuo, Y Nagata, M Wakabayashi, et al.: Impact of Inflammation and Sarcopenia on Outcomes after Stereotactic Body Radiotherapy for T1N0M0 Non-Small Cell Lung Cancer. IASLC 17th World Conference on Lung Cancer. Dec 2016.

      Y Kumazaki, S Kito, M Nakamura, et al.: Development of a postal audit method for IGRT credentialing in multi-institutional clinical trials in Japan. 111th Scientific Meeting of JSMP. Apr 2016.

      H Okamoto, Y Abe, S Nakamura, et al.: Multi-institutional study of assessment of source dwell position in brachytherapy, 111th Scientific Meeting of JSMP. Apr 2016.

      西尾禎治、加瀬優紀、堀田健二、他: JCOG1315多施設臨床試験肝臓陽子線治療における医学物理検証法. 日本粒子線治療臨床研究会第13回学術大会. 2016年10月.

      加瀬優紀、西尾禎治、瀬川達矢、他: 陽子線治療の訪問調査のための肝臓模擬ファントムの線量測定運用試験. 日本放射線腫瘍学会第29回学術大会. 2016年11月.

      M Hussein M, D Eaton, P Greer, et al.: A virtual dosimetry audit – towards transferability between global QA groups in clinical trials. The 36th ESTRO Annual Meeting. May 2017.

      岡本裕之: 第59回日本婦人科腫瘍学会学術講演会、シンポジウム「婦人科腫瘍に対する高精度放射線治療：現状と今後の展望 -放射線治療における医学物理士の役割-」. 2017年7月.

      小澤修一: 体幹部定位放射線治療の臨床試験における呼吸性移動への対応. 第30回高精度放射線外部照射部会学術大会シンポジウム３「IMRTにおける呼吸性移動問題」. 2017年3月.

      M Hussein, D Eaton, P Greer, et al.: A virtual dosimetry audit – towards transferability between global QA groups in clinical trials. The 36th ESTRO Annual Meeting. May 2017.

      T Nishio: “Activity of Medical Physics Working Group in clinical trial for radiotherapy,” Lunch Time Lecture 1, The 115th Scientific Meeting of JSMP. Apr 2018.

   4. 総説・解説

      Y Nagata, M Hiraoka: A phase-II study of the stereotactic body radiotherapy for T1N0M0 non-small cell lung cancer. 第10回日本高精度放射線外部照射研究会. 2004年7月.

      永田 靖、平岡真寛: JCOG0403 T1N0M0非小細胞肺癌に対する体幹部定位照射.第14回日本定位放射線治療学会. 2005年9月.

      M Hiraoka: A JCOG trial for SRT of NSCLC. The 11th International Association for the study of Lung Cancer Workshop. Sep 2006.

      石倉聡: 臨床試験(JCOG)における放射線治療の品質管理. 第44回日本癌治療学会総会、シンポジウム「肺がんの化学療法・放射線療法：現在と未来」. 2006年10月.

      T Kodaira: Definitive IMRT for head and neck cancer patients. Current Japanese status and perspectives. 15th International congress of radiation research. May 2015.

      N Shikama: Update of Radiotherapy for Breast Cancer in Japan: 15th International Congress of Radiation Research. May 2015.

      T Kodaira: How do we adequetly treat with IMRT for locally advanced head and neck cancer ? 4th Congress of Asian Society of Head and Neck Oncology. Jun 2015.

      T Toita: Chemoradiotherapy for uterine cervical cancer. Radiation Oncology Update: Chemoradiotherapy. The 15th International Congress of Radiation Research. May 2015.

      T Koidaira: Definitive IMRT for head and neck cancer patients. Current Japanese status and perspectives. The 15th International Congress of Radiation Research. May 2015.

      古平 毅：強度変調放射線治療の進歩：最新情報　第53回癌治療学会　教育シンポジウム. 2015年10月.

      T Kodaira: Trilateral symposium Free-paper 2: Radiation therapy for head and neck cancers (IGRT, IMRT, etc.): Prospective clinical trials on IMRT for head and neck cancers in Japan. 28回日本放射線腫瘍学会 2015年11月

      T Toita, N Murakami, F Isohashi, et al.:. Current status of IMRT for cervical cancer. Symposium 5- Radiation Oncology, The 4th Biennial Meeting of Asian Society of Gynecologic Oncology. Nov 2015.

      古平 毅：頭頸部がん放射線治療の進歩と今後の展望　第40回頭頸部癌学会教育講演 2016年 6月

      K Ishikawa, M Inada, K Fukuda, et al.: Pharyngeal constrictor muscle (PCM) sparing and dysphagia toxicity in the treatment of intensity modulated radiation therapy for nasopharyngeal cancer (NPC). The 58th Annual Meeting of the American Society for Radiation Oncology. Sep 2016.

      戸板孝文: 子宮頸癌広汎子宮全摘出術後: 放射線療法 vs 化学療法. 〜子宮頸癌Stage IB2, 広汎子宮全摘出の術後, リンパ節転移陽性例の場合〜 放射線療法の立場から. クリニカルディベートIII. 第13回日本婦人科がん会議. 2016年9月.

      S Ishikura: Modern Treatment Techniques in Lung Cancer: The Advantages of Conformal Radiotherapy, IMRT and Proton Therapy. The 17th IASLC World Conference on Lung Cancer. Dec 2016.

      古平 毅：頭頸部癌治療にIMRTが与えた影響. 第４１回頭頸部がん学会 シンポジウム. 2017年6月.

      T Koidara: International symposium Treatment strategy for head and neck cancer 11/18 IMRT for head and neck cancer 30th 日本放射線腫瘍学会 Nov 2017

      野崎美和子：乳房温存術後全乳房照射の有害事象. 第30回日本放射線腫瘍学会　パネルディスカッション. 2017年11月.

      T Kodaira: JASTRO-ESTRO joint symposium (international session)：Role of the altered fractionated radiotherapy for head and neck cancer. The practical value and clinical limitation.　第31回日本放射線腫瘍学会. 2018年10月.

      古平　毅：放射線治療はどう進んでいるか　照射法の進歩.　シンポジウム　第43回日本頭頸部癌学会. 2019年6月

      T Kodaira: New Approach of HPV(+) vs HPV(-) Oropharyngeal Cancer De-Escalate Treatment for HPV(+) Oropharyngeal Cancer : Radiation Therapy. 6th Congress of Asian Society of Head and Nexk Oncology. Mar 2019.

      T Kodaira: Treatment strategy for oropharyngeal cancer Radiotherapy. 6th Congress of Asian Society of Head and Nexk Oncology. Mar 2019.